Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children

被引:60
作者
Renard, Cecile [1 ]
Barlogis, Vincent [2 ]
Mialou, Valerie [1 ]
Galambrun, Claire [2 ]
Bernoux, Delphine [2 ]
Goutagny, Marie Pierre [1 ]
Glasman, Laurence [2 ]
Loundou, Anderson Dieudonne [3 ]
Poitevin-Later, Francoise [4 ]
Dignat-George, Francoise [5 ]
Dubois, Valerie [6 ]
Picard, Christophe [7 ]
Chabannon, Christian [8 ,9 ]
Bertrand, Yves [1 ]
Michel, Gerard [2 ]
机构
[1] Univ Lyon 1, Hosp Civils Lyon, Inst Hematol & Oncol Pediat, F-69008 Lyon, France
[2] Univ Marseille, Hop Enfants La Timone, Assistance Publ Hop Marseille, Serv Hematol Pediat,Fac Med, Marseille, France
[3] Fac Med Marseille, Lab Sante Publ, F-13385 Marseille, France
[4] Hop Edouard Herriot, Immunol Lab, Lyon, France
[5] Hop Conception, Hematol Lab, Marseille, France
[6] EFS Rhone Alpes, Lab Histocompatibil, Lyon, France
[7] EFS Alpes Mediterrannee, Immunogenet Lab, Marseille, France
[8] Inst J Paoli I Calmettes, Ctr Therapie Cellulaire & Genique, F-13009 Marseille, France
[9] INSERM, CIC B510, F-13258 Marseille, France
关键词
bone marrow transplantation; cord blood stem cells transplantation; T-lymphocytes; B-lymphocytes; paediatrics; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; IMMUNE RECONSTITUTION; COMPETING RISKS; THYMIC FUNCTION; ACUTE-LEUKEMIA; T-CELLS; RECOVERY; SUBPOPULATIONS; INFECTIONS;
D O I
10.1111/j.1365-2141.2010.08409.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P>We report the post-transplant lymphocyte subset recovery of 226 children treated with Unrelated Cord Blood transplant (UCBT) (n = 112) or Unrelated Bone Marrow Transplant (UBMT) (n = 114) for malignant or non-malignant diseases. Absolute numbers of natural killer (NK), B and T cells were monitored by flow cytometry up to 5 years post-transplant. Immunological endpoints were: time to achieve a CD3+ cell count > 0 center dot 5 and 1 center dot 5 x 109/l, CD4+ > 0 center dot 2 and 0 center dot 5 x 109/l, CD8+ > 0 center dot 25 x 109/l, CD19+ > 0 center dot 2 x 109/l, NK > 0 center dot 1 x 109/l. These endpoints were analysed through the use of cumulative incidence curves in the context of competing risks. CD8+ T cell recovery was delayed after UCBT with a median time to reach CD8+ T cells > 0 center dot 25 x 109/l of 7 center dot 7 months whereas it was 2 center dot 8 months in UBMT (P < 0 center dot 001). B cell recovery was better in UCBT, with a median time to reach CD19+ cells > 0 center dot 2 x 109/l of 3 center dot 2 months in UCBT and 6 center dot 4 months in UBMT (P = 0 center dot 03). Median time for CD4+ T cell and NK cell recovery was similar in UCBT and UBMT. CD4+ T cells recovery was negatively correlated to age (better reconstitution in younger patients, P = 0 center dot 002). CD8+ T cells recovery was shorter in recipients with a positive cytomegalovirus serology (P = 0 center dot 001).
引用
收藏
页码:322 / 330
页数:9
相关论文
共 39 条
[31]   Clinical use of umbilical cord blood hematopoietic stem cells [J].
Rocha, V ;
Gluckman, E .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) :34-41
[32]   Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-Identical sibling. [J].
Rocha, V ;
Wagner, JE ;
Sobocinski, KA ;
Klein, JP ;
Zhang, MJ ;
Horowitz, MM ;
Gluckman, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1846-1854
[33]   Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia [J].
Rocha, V ;
Cornish, J ;
Sievers, EL ;
Filipovich, A ;
Locatelli, F ;
Peters, C ;
Remberger, M ;
Michel, G ;
Arcese, W ;
Dallorso, S ;
Tiedemann, K ;
Busca, A ;
Chan, KW ;
Kato, S ;
Ortega, J ;
Vowels, M ;
Zander, A ;
Souillet, G ;
Oakill, A ;
Woolfrey, A ;
Pay, AL ;
Green, A ;
Garnier, F ;
Ionescu, I ;
Wernet, P ;
Sirchia, G ;
Rubinstein, P ;
Chevret, S ;
Gluckman, E .
BLOOD, 2001, 97 (10) :2962-2971
[34]   Lymphocyte subsets in healthy children from birth through 18 years of age: The pediatric AIDS clinical trials group P1009 study [J].
Shearer, WT ;
Rosenblatt, HM ;
Gelman, RS ;
Oymopito, R ;
Plaeger, S ;
Stiehm, ER ;
Wara, DW ;
Douglas, SD ;
Luzuriaga, K ;
McFarland, EJ ;
Yogev, R ;
Rathore, MH ;
Levy, W ;
Graham, BL ;
Spector, SA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (05) :973-980
[35]  
SZYDLO R, 2008, EBMT HDB HAEMATOPOIE, P328
[36]   A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation [J].
Talvensarri, K ;
Clave, E ;
Douay, C ;
Rabian, C ;
Garderet, L ;
Busson, M ;
Garnier, F ;
Douek, D ;
Gluckman, E ;
Charron, D ;
Toubert, A .
BLOOD, 2002, 99 (04) :1458-1464
[37]  
Thomson BG, 2000, BLOOD, V96, P2703
[38]   Infectious complications following unrelated cord blood transplantation [J].
van Burik, J.-A. ;
Brunstein, C. G. .
VOX SANGUINIS, 2007, 92 (04) :289-296
[39]   Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation [J].
Weinberg, K ;
Blazar, BR ;
Wagner, JE ;
Agura, E ;
Hill, BJ ;
Smogorzewska, M ;
Koup, RA ;
Betts, MR ;
Collins, RH ;
Douek, DC .
BLOOD, 2001, 97 (05) :1458-1466